Headquartered in Madrid, PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes its inspiration from the sea to discover molecules with antitumor activity. It is a company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. Its commitment to patients and to research has made it one of the world leaders in the discovery of antitumor drugs of marine origin.
PharmaMar has a pipeline of drug candidates and a robust R&D oncology program. It develops and commercializes Yondelis® in Europe and has other clinical-stage programs under development for several types of solid cancers: lurbinectedin (PM1183), PM184 and PM14. With subsidiaries in Germany, Italy, France, Switzerland, Belgium, Austria and the United States. PharmaMar wholly owns other companies: GENOMICA, a molecular diagnostics company; Sylentis, dedicated to researching therapeutic applications of gene silencing (RNAi). To learn more about PharmaMar, please visit us at www.pharmamar.com.
|
|
|
|
|
201-500 employees
View all PharmaMar employees
|
|
|
Biotechnology Research
|
|
|
$50M–$100M
|
|
|
+34 91 444 45 00
|
|
|
Avda. De los Reyes, 1, Colmenar Viejo, Madrid 28770, ES
|
|
|
1986
|
|
|
Oncology, Drug Discovery, Drug Development, Pharmaceutical Marketing
|
Isabel Lozano is the CEO of PharmaMar. To contact Isabel Lozano email at [email protected].
PharmaMar headquarters is located at Avda. De los Reyes, 1, Colmenar Viejo, Madrid 28770, ES.
PharmaMar generates an estimated $50M–$100M annually, based on industry analysis and publicly available market data.
You can contact PharmaMar by calling +34 91 444 45 00.
PharmaMar headquarters is located at Avda. De los Reyes, 1, Colmenar Viejo, Madrid 28770, ES.
PharmaMar generates an estimated $50M–$100M annually, based on industry analysis and publicly available market data.
You can contact PharmaMar by calling +34 91 444 45 00.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.